Share：
Share this content in WeChat
X
[Chinese][PDF]4916
• Review •
Advances in MRI study of structural and functional changes in the limbic system of Parkinson's disease with depression
QU Mingrui  GAO Bingbing  MIAO Yanwei 

Cite this article as: QU M R, GAO B B, MIAO Y W. Advances in MRI study of structural and functional changes in the limbic system of Parkinson's disease with depression[J]. Chin J Magn Reson Imaging, 2023, 14(12): 127-131. DOI:10.12015/issn.1674-8034.2023.12.022.


[Abstract] Depression is one of the most common non-motor symptoms of Parkinson's disease (PD). It usually appears in the early stage of the disease, seriously affecting the quality of life and increasing the burden of the disease. Neuroimaging has found a wide range of structural and functional abnormalities in the limbic system, especially the orbitofrontal lobe, anterior cingulate gyrus, amygdala and hippocampus are closely related to the pathophysiology of PD with depression (DPD). Therefore, taking the limbic system as a starting point, this paper reviews the MRI studies related to the changes of brain structure and function in DPD patients, in order to provide new ideas for future research.
[Keywords] Parkinson's disease；depression；limbic system；magnetic resonance imaging；structural magnetic resonance imaging；functional magnetic resonance imaging；diffusion tensor imaging

QU Mingrui   GAO Bingbing   MIAO Yanwei*  

Department of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China

Corresponding author: MIAO Y W, E-mail: ywmiao716@163.com

Conflicts of interest   None.

Received  2023-07-25
Accepted  2023-11-06
DOI: 10.12015/issn.1674-8034.2023.12.022
Cite this article as: QU M R, GAO B B, MIAO Y W. Advances in MRI study of structural and functional changes in the limbic system of Parkinson's disease with depression[J]. Chin J Magn Reson Imaging, 2023, 14(12): 127-131. DOI:10.12015/issn.1674-8034.2023.12.022.

[1]
JELLINGER K A. The pathobiological basis of depression in Parkinson disease: challenges and outlooks[J]. J Neural Transm (Vienna), 2022, 129(12): 1397-1418. DOI: 10.1007/s00702-022-02559-5.
[2]
AGÜERA-ORTIZ L, GARCÍA-RAMOS R, GRANDAS PÉREZ F J, et al. Focus on depression in Parkinson's disease: A delphi consensus of experts in psychiatry, neurology, and geriatrics[J/OL]. Parkinsons Dis, 2021, 2021: 6621991 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/33628415/. DOI: 10.1155/2021/6621991.
[3]
MENDONÇA I P, DUARTE-SILVA E, CHAVES-FILHO A J M, et al. Neurobiological findings underlying depressive behavior in Parkinson's disease: A review[J/OL]. Int Immunopharmacol, 2020, 83: 106434 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/32224442/. DOI: 10.1016/j.intimp.2020.106434.
[4]
LINTEL H, CORPUZ T, PARACHA S U, et al. Mood disorders and anxiety in Parkinson's disease: Current concepts[J]. J Geriatr Psychiatry Neurol, 2021, 34(4): 280-288. DOI: 10.1177/08919887211018267.
[5]
LAUX G. Parkinson and depression: review and outlook[J]. J Neural Transm (Vienna), 2022, 129(5-6): 601-608. DOI: 10.1007/s00702-021-02456-3.
[6]
MORGAN H E, LEDBETTER C R, FERRIER C, et al. Altered cortico-limbic network connectivity in Parkinsonian depression: The effect of antidepressants[J]. J Parkinsons Dis, 2018, 8(3): 429-440. DOI: 10.3233/jpd-171204.
[7]
LIM J, BANG Y, CHOI H J. Abnormal hippocampal neurogenesis in Parkinson's disease: relevance to a new therapeutic target for depression with Parkinson's disease[J]. Arch Pharm Res, 2018, 41(10): 943-954. DOI: 10.1007/s12272-018-1063-x.
[8]
BANWINKLER M, THEIS H, PRANGE S, et al. Imaging the limbic system in Parkinson's disease-A review of limbic pathology and clinical symptoms[J/OL]. Brain Sci, 2022, 12(9): 1248 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/36138984/. DOI: 10.3390/brainsci12091248.
[9]
GIGUÈRE N, BURKE NANNI S, TRUDEAU L E. On cell loss and selective vulnerability of neuronal populations in Parkinson's disease[J/OL]. Front Neurol, 2018, 9: 455 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/29971039/. DOI: 10.3389/fneur.2018.00455.
[10]
ROLLS E T. Emotion, motivation, decision-making, the orbitofrontal cortex, anterior cingulate cortex, and the amygdala[J]. Brain Struct Funct, 2023, 228(5): 1201-1257. DOI: 10.1007/s00429-023-02644-9.
[11]
PRANGE S, KLINGER H, LAURENCIN C, et al. Depression in Patients with Parkinson's disease: Current understanding of its neurobiology and implications for treatment[J]. Drugs Aging, 2022, 39(6): 417-439. DOI: 10.1007/s40266-022-00942-1.
[12]
SONG S, LUO Z, LI C, et al. Depressive symptoms before and after Parkinson's diagnosis-A longitudinal analysis[J/OL]. PLoS One, 2022, 17(7): e0272315 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/35905124/. DOI: 10.1371/journal.pone.0272315.
[13]
ZHENG P, WU J, ZHANG H, et al. The gut microbiome modulates gut-brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression[J]. Mol Psychiatry, 2021, 26(6): 2380-2392. DOI: 10.1038/s41380-020-0744-2.
[14]
FELDMANN A, ILLES Z, KOSZTOLANYI P, et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study[J]. Mov Disord, 2008, 23(1): 42-46. DOI: 10.1002/mds.21765.
[15]
LI Y, HUANG P, GUO T, et al. Brain structural correlates of depressive symptoms in Parkinson's disease patients at different disease stage[J/OL]. Psychiatry Res Neuroimaging, 2020, 296: 111029 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/31918166/. DOI: 10.1016/j.pscychresns.2019.111029.
[16]
TINAZ S, KAMEL S, ARAVALA S S, et al. Distinct neural circuits are associated with subclinical neuropsychiatric symptoms in Parkinson's disease[J/OL]. J Neurol Sci, 2021, 423: 117365 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/33636663/. DOI: 10.1016/j.jns.2021.117365.
[17]
YE B S, JEON S, YOON S, et al. Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 2018, 89(2): 197-204. DOI: 10.1136/jnnp-2017-316075.
[18]
DENG J H, ZHANG H W, LIU X L, et al. Morphological changes in Parkinson's disease based on magnetic resonance imaging: A mini-review of subcortical structures segmentation and shape analysis[J]. World J Psychiatry, 2022, 12(12): 1356-1366. DOI: 10.5498/wjp.v12.i12.1356.
[19]
WANG H, XU J, YU M, et al. Functional and structural alterations as diagnostic imaging markers for depression in de novo Parkinson's disease[J/OL]. Front Neurosci, 2023, 17: 1101623 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/36908791/. DOI: 10.3389/fnins.2023.1101623.
[20]
GOTO M, KAMAGATA K, HATANO T, et al. Depressive symptoms in Parkinson's disease are related to decreased left hippocampal volume: correlation with the 15-item shortened version of the Geriatric Depression Scale[J]. Acta Radiol, 2018, 59(3): 341-345. DOI: 10.1177/0284185117719100.
[21]
GYÖRFI O, NAGY H, BOKOR M, et al. Reduced CA2-CA3 hippocampal subfield volume is related to depression and normalized by l-DOPA in newly diagnosed Parkinson's disease[J/OL]. Front Neurol, 2017, 8: 84 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/28367136/. DOI: 10.3389/fneur.2017.00084.
[22]
BHOME R, ZARKALI A, THOMAS G E C, et al. Thalamic white matter macrostructure and subnuclei volumes in Parkinson's disease depression[J/OL]. NPJ Parkinsons Dis, 2022, 8(1): 2 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/35013327/. DOI: 10.1038/s41531-021-00270-y.
[23]
YIN W, LI A, YANG B, et al. Abnormal cortical atrophy and functional connectivity are associated with depression in Parkinson's disease[J/OL]. Front Aging Neurosci, 2022, 14: 957997 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/36118705/. DOI: 10.3389/fnagi.2022.957997.
[24]
CHAGAS M H N, TUMAS V, PENA-PEREIRA M A, et al. Neuroimaging of major depression in Parkinson's disease: Cortical thickness, cortical and subcortical volume, and spectroscopy findings[J]. J Psychiatr Res, 2017, 90: 40-45. DOI: 10.1016/j.jpsychires.2017.02.010.
[25]
HUANG P, LOU Y, XUAN M, et al. Cortical abnormalities in Parkinson's disease patients and relationship to depression: A surface-based morphometry study[J]. Psychiatry Res Neuroimaging, 2016, 250: 24-28. DOI: 10.1016/j.pscychresns.2016.03.002.
[26]
HANGANU A, BRUNEAU M A, DEGROOT C, et al. Depressive symptoms in Parkinson's disease correlate with cortical atrophy over time[J]. Brain Cogn, 2017, 111: 127-133. DOI: 10.1016/j.bandc.2016.11.001.
[27]
ANSARI M, ADIB MORADI S, GHAZI SHERBAF F, et al. Comparison of structural connectivity in Parkinson's disease with depressive symptoms versus non-depressed: a diffusion MRI connectometry study[J]. Int Psychogeriatr, 2019, 31(1): 5-12. DOI: 10.1017/s1041610218000170.
[28]
LI Z, LIU W, XIAO C, et al. Abnormal white matter microstructures in Parkinson's disease and comorbid depression: A whole-brain diffusion tensor imaging study[J/OL]. Neurosci Lett, 2020, 735: 135238 [2023-07-25]. DOI: 10.1016/j.neulet.2020.135238.
[29]
WU J Y, ZHANG Y, WU W B, et al. Impaired long contact white matter fibers integrity is related to depression in Parkinson's disease[J]. CNS Neurosci Ther, 2018, 24(2): 108-114. DOI: 10.1111/cns.12778.
[30]
SHEN Q, LIU Y, GUO J, et al. Impaired white matter microstructure associated with severe depressive symptoms in patients with PD[J]. Brain Imaging Behav, 2022, 16(1): 169-175. DOI: 10.1007/s11682-021-00488-7.
[31]
YANG Y, YANG Y, PAN A, et al. Identifying depression in Parkinson's disease by using combined diffusion tensor imaging and support vector machine[J/OL]. Front Neurol, 2022, 13: 878691 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/35795798/. DOI: 10.3389/fneur.2022.878691.
[32]
GOU L, ZHANG W, LI C, et al. Structural brain network alteration and its correlation with structural impairments in patients with depression in de novo and drug-naïve Parkinson's disease[J/OL]. Front Neurol, 2018, 9: 608 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/30093879/. DOI: 10.3389/fneur.2018.00608.
[33]
PRANGE S, METEREAU E, MAILLET A, et al. Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease[J]. Mov Disord, 2019, 34(11): 1644-1654. DOI: 10.1002/mds.27793.
[34]
MOONEN A J H, WEISS P H, WIESING M, et al. An fMRI study into emotional processing in Parkinson's disease: Does increased medial prefrontal activation compensate for striatal dysfunction?[J/OL]. PLoS One, 2017, 12(5): e0177085 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/28486506/. DOI: 10.1371/journal.pone.0177085.
[35]
DU PLESSIS S, BEKKER M, BUCKLE C, et al. Association between a variable number tandem repeat polymorphism within the DAT1 gene and the mesolimbic pathway in Parkinson's disease[J/OL]. Front Neurol, 2020, 11: 982 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/32982958/. DOI: 10.3389/fneur.2020.00982.
[36]
DI TELLA S, ANZUINO I, BIASSONI F, et al. The role of the dorsal striatum in the recognition of emotions expressed by voice in Parkinson's disease[J]. Neurol Sci, 2021, 42(5): 2085-2089. DOI: 10.1007/s10072-020-04959-5.
[37]
QIU Y H, NIE K, GAO Y Y, et al. Regional homogeneity in the patients of Parkinson disease with depression: a resting-state functional magnetic resonance imaging study[J]. Chin J Magn Reson Imaging, 2020, 46(4): 202-209. DOI: 10.3969/j.issn.1002-0152.2020.04.003.
[38]
SU D, CUI Y, LIU Z, et al. Altered brain activity in depression of Parkinson's disease: A meta-analysis and validation study[J/OL]. Front Aging Neurosci, 2022, 14: 806054 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/35401154/. DOI: 10.3389/fnagi.2022.806054.
[39]
ZHANG H, QIU Y, LUO Y, et al. The relationship of anxious and depressive symptoms in Parkinson's disease with voxel-based neuroanatomical and functional connectivity measures[J]. J Affect Disord, 2019, 245: 580-588. DOI: 10.1016/j.jad.2018.10.364.
[40]
HU X, SONG X, YUAN Y, et al. Abnormal functional connectivity of the amygdala is associated with depression in Parkinson's disease[J]. Mov Disord, 2015, 30(2): 238-244. DOI: 10.1002/mds.26087.
[41]
TESSITORE A, CIRILLO M, DE MICCO R. Functional connectivity signatures of Parkinson's disease[J]. J Parkinsons Dis, 2019, 9(4): 637-652. DOI: 10.3233/jpd-191592.
[42]
WANG J, SUN L, CHEN L, et al. Common and distinct roles of amygdala subregional functional connectivity in non-motor symptoms of Parkinson's disease[J/OL]. NPJ Parkinsons Dis, 2023, 9(1): 28 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/36806219/. DOI: 10.1038/s41531-023-00469-1.
[43]
WEI L, HU X, YUAN Y, et al. Abnormal ventral tegmental area-anterior cingulate cortex connectivity in Parkinson's disease with depression[J]. Behav Brain Res, 2018, 347: 132-139. DOI: 10.1016/j.bbr.2018.03.011.
[44]
LI H D, WANG J, NIU J L. Brain complexity in the patients of Parkinson's disease with depression: a resting-state functional magnetic resonance imaging study[J]. Chin J Magn Reson Imaging, 2022, 13(7): 90-95. DOI: 10.12015/issn.1674-8034.2022.07.016.
[45]
LIAO H, YI J, CAI S, et al. Changes in degree centrality of network nodes in different frequency bands in Parkinson's disease with depression and without depression[J/OL]. Front Neurosci, 2021, 15: 638554 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/33828449/. DOI: 10.3389/fnins.2021.638554.
[46]
HUANG P, GUAN X, GUO T, et al. Damaged insula network contributes to depression in Parkinson's disease[J/OL]. Front Psychiatry, 2020, 11: 119 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/32210851/. DOI: 10.3389/fpsyt.2020.00119.
[47]
LIAO H, CAI S, SHEN Q, et al. Networks are associated with depression in patients with Parkinson's disease: A resting-state imaging study[J/OL]. Front Neurosci, 2020, 14: 573538 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/33633526/. DOI: 10.3389/fnins.2020.573538.
[48]
QIU Y H, HUANG Z H, GAO Y Y, et al. Alterations in intrinsic functional networks in Parkinson's disease patients with depression: A resting-state functional magnetic resonance imaging study[J]. CNS Neurosci Ther, 2021, 27(3): 289-298. DOI: 10.1111/cns.13467.
[49]
WEI X, YAN R, CHEN Z, et al. Combined diffusion tensor imaging and arterial spin labeling as markers of early Parkinson's disease[J/OL]. Sci Rep, 2016, 6: 33762 [2023-07-25]. https://pubmed.ncbi.nlm.nih.gov/27646647/. DOI: 10.1038/srep33762.
[50]
LI X Y, TIAN Y T, WANG X N, et al. Cerebral perfusion in Parkinson's disease with depression: An arterial spin labeling MRI study[J]. Chin J Magn Reson Imaging, 2023, 14(1): 6-12. DOI: 10.12015/issn.1674-8034.2023.01.002.

PREV Research progress of brain structure and resting-state functional MRI in patients with breast cancer chemotherapy-related cognitive impairment
NEXT Progress of motor recovery-related neuroplasticity after stroke in MRI studies
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn